α-catenin

Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer

(2015)   Oncotarget

Wnt and Kras signaling-dark siblings in lung cancer

(2015) Eugenia C. Pacheco-Pinedo et al.   Oncotarget

Down-regulation of Sox7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer

(2015) David W Chan et al.   Oncotarget

Calcein-effluxing human colon cancer cells are enriched for self-renewal capacity and depend on β-catenin

(2015) Joshua E. Allen et al.   Oncotarget

A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis

(2014) Q. Chen et al.   GENES & DEVELOPMENT

α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling

(2014) Hai-long Piao et al.   NATURE CELL BIOLOGY

Targeting of Smoothened for therapeutic gain

(2014) Martial Ruat et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation

(2013) Chang Hee Kim et al.   CELL CYCLE

Wnt signaling in adult intestinal stem cells and cancer

(2013) Michaela Krausova et al.   CELLULAR SIGNALLING

 -Catenin interacts with APC to regulate  -catenin proteolysis and transcriptional repression of Wnt target genes

(2013) S. H. Choi et al.   GENES & DEVELOPMENT

YAP oncogene overexpression supercharges colon cancer proliferation

(2012) Joseph Avruch et al.   CELL CYCLE

Human telomerase reverse transcriptase (hTERT) is a target gene of β-catenin in human colorectal tumors

(2012) Stefanie Jaitner et al.   CELL CYCLE

Determinants of Wnt/β-catenin pathway dependency in colorectal cancer

(2012) Alix Scholer-Dahirel et al.   CELL CYCLE

MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling

(2012) Yong Hoon Cha et al.   CELL CYCLE

Regulating the response to targeted MEK inhibition in melanoma

(2012) William H. Conrad et al.   CELL CYCLE

Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities

(2012) D. W. Craig et al.   MOLECULAR CANCER THERAPEUTICS

LIF-ting Hippo averts metastasis

(2012) Stefano Piccolo   NATURE MEDICINE

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

(2012) Dahu Chen et al.   NATURE MEDICINE

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain

(2012) J. M. Lamar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation

(2011) Karin Schlegelmilch et al.   CELL

 -Catenin Is a Tumor Suppressor That Controls Cell Accumulation by Regulating the Localization and Activity of the Transcriptional Coactivator Yap1

(2011) M. R. Silvis et al.   Science Signaling

Wnt/β-catenin signaling pathway may regulate cell cycle and expression of cyclin A and cyclin E protein in hepatocellular carcinoma cells

(2010) Xinhong Wang et al.   CELL CYCLE

Targeting Hedgehog -- a Cancer Stem Cell Pathway

(2010) A. A. Merchant et al.   CLINICAL CANCER RESEARCH

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version

(2010) B. Zhao et al.   GENES & DEVELOPMENT

α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation

(2010) Haitao Ji et al.   JOURNAL OF NEURO-ONCOLOGY

Genome remodelling in a basal-like breast cancer metastasis and xenograft

(2010) Li Ding et al.   NATURE

Adherens junctions: from molecules to morphogenesis

(2010) Tony J. C. Harris et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression

(2010) H. Song et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

(2010) L. Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis

(2010) K.-P. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modulation of the Tumor Suppressor Protein α-Catenin by Ischemic Microenvironment

(2009) Claire L. Plumb et al.   AMERICAN JOURNAL OF PATHOLOGY

Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations

(2009) Antoinette Hollestelle et al.   BREAST CANCER RESEARCH AND TREATMENT

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

(2009) Dawang Zhou et al.   CANCER CELL

Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies

(2009) Y. Ye et al.   CANCER RESEARCH

Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines

(2009) Noritaka Yamaguchi et al.   CANCER SCIENCE

Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways

(2008) T. T. Onder et al.   CANCER RESEARCH

Wnt/β-catenin signaling: new (and old) players and new insights

(2008) He Huang et al.   CURRENT OPINION IN CELL BIOLOGY

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

(2008) Véronique Baud et al.   NATURE REVIEWS DRUG DISCOVERY

Bench to bedside and back again: Molecular mechanisms of α-catenin function and roles in tumorigenesis

(2007) Jacqueline M. Benjamin et al.   SEMINARS IN CANCER BIOLOGY